Open Access
Issue
Med Buccale Chir Buccale
Volume 16, Number 3, juillet 2010
Page(s) 159 - 162
Section Observations cliniques / Case reports
DOI https://doi.org/10.1051/mbcb/2010013
Published online 07 April 2010
  1. Amagai M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 1996;11:319-52. [PubMed]
  2. Scully C, Challacombe SJ. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management. Crit Rev Oral Biol Med 2002;13:397-408. [CrossRef] [PubMed]
  3. Lever WF, Schaumburg-Lever G. Immunosuppressants prednisone in pemphigus vulgaris. Therapeutic results obtained on 63 patients between 1961 and 1975. Arch Dermatol 1977;113:1236-41. [CrossRef] [PubMed]
  4. Sirois D, Leigh JE, Sollecito TP. Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis. J Am Dent Assoc 2000;131:1156-60. [PubMed]
  5. Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol 2000;42:422-7. [CrossRef] [PubMed]
  6. Saha M, Powell AM, Bhogal B, Black MM, Groves RW. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus. Br J Dermatol 2009 Nov 18 (Epub ahead of printing).
  7. Hashimoto T. Treatment strategies for pemphigus vulgaris in Japan. Expert Opin Pharmacother 2008;9:1519-30. [CrossRef] [PubMed]
  8. Esmaili N, Chams-Davatchi C, Valikhani M, Farshidfar F, Parvaneh N, Tamizifar B. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent. Eur J Dermatol 2008;18:159-64. [PubMed]
  9. Fellner M, Sawhney VK. Current therapy of pemphigus vulgaris. Mt Sinai J Med 2001;68:268-78. [PubMed]
  10. Lamey PJ, Rees TD, Binnie WH, Wright JM, Rankin KV, Simpson NB. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol 1992;74:54-7. [CrossRef] [PubMed]
  11. Ahmed AR. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment. J Am Acad Dermatol 2001;45:679-90. [CrossRef] [PubMed]
  12. Sami N, Qureshi A, Ahmed AR. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus. Eur J Dermatol 2002;12:174-8. [PubMed]
  13. Dahl MV, Brigdes AG. Intravenous immune globulin: fighting antibodies with antibodies. J Am Acad Dermatol 2001;45:775-83. [CrossRef] [PubMed]
  14. Scully C, Paes de Almeida O, Porter SR, Gilkes JJ. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol 1999;140:84-9. [CrossRef] [PubMed]
  15. Epstein JB, Gorsky M, Epstein MS. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:56-61. [CrossRef] [PubMed]
  16. Borradori L, Lombardi T, Samson J, Girardet C, Saurat JH, Hügli A. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma associated paraneoplastic pemphigus. Arch Dermatol 2001;137:269-72. [PubMed]
  17. Yeh SW, Sami N, Ahmed RA. Treatment of pemphigus vulgaris: current and emerging options. Am J Clin Dermatol 2005;6:327-42. [CrossRef] [PubMed]
  18. Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M, Valikhani M, Hallaji Z, Barzegari M, Firouz AR, Zakeri M. Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris. Ann Dermatol Venereol 2002;129:23-5. [PubMed]
  19. Morris RE, Wang J, Blum JR, Flavin T, Murphy MP, Almqvist SJ, Chu N, Tam YL, Kaloostian M, Allison AC. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant Proc 1991;23:19-25. [PubMed]
  20. Coronel-Pérez IM, Rodríguez-Rey EM, Pérez-Bernal AM, Camacho FM. Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006. Actas Dermosifiliogr 2009;100:121-5. [CrossRef] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.